Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women Symbol

@article{Baraona2017TobaccoHN,
  title={Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women Symbol},
  author={Kim L. Baraona and Dawn L Lovelace and Julie L Daniels and Linda R McDaniel},
  journal={Journal of Midwifery and Women'S Health},
  year={2017},
  volume={62},
  pages={253–269}
}
&NA; Firsthand and secondhand tobacco use is linked to a multitude of harmful illnesses, adverse perinatal outcomes, and death. Cessation attempts among women may be hampered by their unique biologic response to nicotine. Current research has revealed epigenetic changes from intrauterine nicotine exposure that have intergenerational consequences. Multiple studies have demonstrated the efficacy of various pharmacologic tobacco cessation interventions in conjunction with behavioral counseling… 

Tables from this paper

Early life exposure to nicotine: Postnatal metabolic, neurobehavioral and metabolic outcomes and the development of childhood cancers.
TLDR
The long-term effects of fetal and neonatal nicotine exposure on postnatal health is examined and animal studies suggest that nicotine alone may be a key chemical responsible for many of the long- term effects associated with maternal cigarette smoking on the offspring.
Smoking cessation in pregnancy: a continuing challenge in the United States
TLDR
The current state and future direction of smoking cessation in pregnancy in the US is reviewed, and population-based and individual smoking cessation interventions are reviewed in the context of pregnancy and barriers to cessation among US women.
Tobacco dependence treatment for special populations: challenges and opportunities
TLDR
More resources are needed if the authors are to reduce health disparities in these vulnerable populations and more effort should be focused on integrating smoking cessation treatment in the specialized care settings frequented by these subpopulations.
Biological effects of nicotine exposure: A narrative review of the scientific literature.
TLDR
The results from animal studies indicate that nicotine has the potential to act across many mechanisms during fetal development and more studies are needed to address questions regarding nicotine exposure in humans, and this may lead to additional guidance concerning new ENDS entering the market.
[Smoking cessation and pregnancy].
Cardiovascular, carcinogenic and reproductive effects of nicotine exposure: A narrative review of the scientific literature
TLDR
The results from animal studies indicate that nicotine has the potential to act across many mechanisms during fetal development and more studies are needed to address questions regarding nicotine exposure in humans, and this may lead to additional guidance concerning new ENDS entering the market.
The use of electronic nicotine delivery systems during pregnancy and the reproductive outcomes: A systematic review of the literature
TLDR
No studies of pregnant women exposed to ENDS use and its effect on their fetus or neonates are found and systematic reviews and meta-analysis of studies of women who used smokeless tobacco during pregnancy suggest that prenatal nicotine alone is a risk factor for low birth weight, premature delivery, and stillbirth.
Pharmacologic Treatment of Perinatal Depression.
C57BL/6 Substrain Differences in Pharmacological Effects after Acute and Repeated Nicotine Administration
TLDR
Overall, enhanced nicotine sensitivity to locomotion, hypothermia, antinociception, and anxiety-like behaviors in the B6J mouse substrain compared to B6N is shown.
...
1
2
...

References

SHOWING 1-10 OF 65 REFERENCES
Risks and Benefits of Nicotine to Aid Smoking Cessation in Pregnancy
TLDR
A national registry for NRT use during pregnancy should be created to prospectively collect obstetrical outcome data from NRT efficacy trials and from individual use to determine the safety of NRTUse during pregnancy, especially with respect to uncommon outcomes such as placental abruption.
Pharmacological interventions for promoting smoking cessation during pregnancy.
TLDR
The primary efficacy outcome was smoking cessation in later pregnancy (in all but one trial, at or around delivery); safety was assessed by seven birth outcomes that indicated neonatal well being and there were no trials of varenicline or bupropion.
What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?
  • C. Oncken, H. Kranzler
  • Medicine, Psychology
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
  • 2009
TLDR
These trials showed that NRT did not adversely affect birth outcomes and increased birth weight, and psychosocial interventions should be the first treatment option for pregnant smokers.
Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force
TLDR
This review assessed the benefits and harms of behavioral and pharmacologic interventions for tobacco cessation in adults, including pregnant women, to assist the USPSTF in updating its 2009 recommendation on smoking cessation.
Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
TLDR
The outcome for benefit is continuous or prolonged abstinence at least six months from the start of treatment, and the outcome for harms is the incidence of serious adverse events associated with each of the treatments.
Antidepressants for smoking cessation.
TLDR
There is insufficient evidence that adding bupropion or nortriptyline to nicotine replacement therapy provides an additional long-term benefit, and the antidepressants buPropion and nortriptYline appear to be equally effective and of similar efficacy to Nicotine replacement therapy.
Smoking in pregnancy and lactation: a review of risks and cessation strategies
TLDR
There is evidence that smoking in pregnancy and lactation may cause many adverse affects in the perinatal period, childhood, and up to adulthood, and a number of strategies have been developed to assist pregnant women in quitting smoking.
Smoking cessation therapy during pregnancy.
TLDR
Given the considerable and well-documented adverse effects of antenatal smoking on mother and fetus, pharmacotherapy for smoking cessation should be considered and used accompanied by behavioural counseling and education to maximize quit rates.
Nicotine Gum for Pregnant Smokers: A Randomized Controlled Trial
TLDR
Although nicotine gum did not increase quit rates, use of nicotine gum increased birth weight and gestational age, two key parameters in predicting neonatal wellbeing.
...
1
2
3
4
5
...